Retatrutide in Type 2 Diabetes: Trial Design and Findings | RemedyX Labs Research Library

A research summary of Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People with Type 2 Diabetes, examining retatrutide in type 2 diabetes: trial design and findings. Cited source and RUO context from RemedyX Labs.